DongHyuk Jeon
Director of Production Center Curocell
Mr. Jeon is a Director of quality and manufacturing in Curocell and former QA and Production manager in LG Chem, Life Sciences business. He has over 18 years of pharmaceutical manufacturing and quality assurance experience. His expertise covers both managerial and technical roles.
Seminars
Cell and gene therapy development is advancing toward commercialization faster than most manufacturing,
process development, analytical, and CMC teams can keep pace. This is especially evident as South Korea’s first
CAR‑T therapy enters the market.
Amid ongoing regulatory uncertainty, the primary challenge lies not in clinical performance but in supply chain and process readiness, making now a critical window to build robust, scalable, and compliant manufacturing strategies.
Join this workshop to gain key insights on:
- Systemic Agility: Mitigating material complexities and supply network volatility
- Clinical development of chimeric antigen receptor T-cell therapy manufacturing, formulation and administration
- Ensuring safety and cost efficiency in the scaled manufacturing of cell therapy products
